U.S. Markets close in 4 hrs 11 mins
  • S&P 500

    4,588.14
    +36.46 (+0.80%)
     
  • Dow 30

    35,645.11
    +154.42 (+0.44%)
     
  • Nasdaq

    15,419.56
    +183.73 (+1.21%)
     
  • Russell 2000

    2,284.56
    +32.07 (+1.42%)
     
  • Gold

    1,805.60
    +6.80 (+0.38%)
     
  • EUR/USD

    1.1695
    +0.0088 (+0.7601%)
     
  • 10-Yr Bond

    1.5470
    +0.0180 (+1.18%)
     
  • Vix

    16.45
    -0.53 (-3.12%)
     
  • GBP/USD

    1.3811
    +0.0069 (+0.5000%)
     
  • USD/JPY

    113.3190
    -0.4910 (-0.4314%)
     
  • BTC-USD

    61,281.72
    +2,370.46 (+4.02%)
     
  • CMC Crypto 200

    1,478.23
    +58.85 (+4.15%)
     
  • FTSE 100

    7,240.42
    -12.85 (-0.18%)
     
  • Nikkei 225

    28,820.09
    -278.11 (-0.96%)
     

Moderna’s stock price is ‘ridiculous,’ says BofA analyst

·2 min read
Moderna’s stock price is ‘ridiculous,’ says BofA analyst
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Moderna Inc. have so much that the biotechnology company's valuation is "unjustifiable on a fundamental basis," said analyst Geoff Meacham on Tuesday, as his analysis suggests the stock could fall more than 75% from current levels.